14
Public broadcaster
provisional
Why this rating?
· 1 signal
▾
Signals flagged in the original
- ›vague attribution present
Clinical Trial Shows Promising Results for mRNA Skin Cancer Vaccine
A clinical trial for an experimental skin cancer vaccine by Merck and Moderna has shown significant results in reducing melanoma recurrence and spread. The trial involved 1,137 patients and demonstrated improved survival rates for those receiving the personalized mRNA vaccine alongside standard treatment. Regulatory discussions are planned following these promising findings.
People
Stéphane Bancel
Dr. Murad Alam
Our neutral summary
A clinical trial for an experimental skin cancer vaccine by Merck and Moderna has shown significant results in reducing melanoma recurrence and spread. The trial involved 1,137 patients and demonstrated improved survival rates for those receiving the personalized mRNA vaccine alongside standard treatment. Regulatory discussions are planned following these promising findings.
Read the full story at Fox News — Latest ↗
The reporting belongs to
Fox News — Latest;
we don't reproduce it.
You can compare how outlets framed this story below.